Downloadable PPT - Research To Practice
... Investigator Commentary: Phase Ib Study of Pembrolizumab in Classical HL After Disease Progression on Brentuximab Vedotin This study evaluated the effect of pembrolizumab in a cohort of patients with heavily pretreated HL. In the KEYNOTE-013 trial, pembrolizumab is also being investigated in patien ...
... Investigator Commentary: Phase Ib Study of Pembrolizumab in Classical HL After Disease Progression on Brentuximab Vedotin This study evaluated the effect of pembrolizumab in a cohort of patients with heavily pretreated HL. In the KEYNOTE-013 trial, pembrolizumab is also being investigated in patien ...
Seasonal Affective Disorder
... Less light=increased levels of melatonin being released by the brain’s pineal gland Raised melatonin levels = SAD in some people ...
... Less light=increased levels of melatonin being released by the brain’s pineal gland Raised melatonin levels = SAD in some people ...
lection4-1-Rule-Based_Expert_Systems_and_the_MYCIN_Project
... • All data recorded and given, if asked for, by the computer or a human expert • All decisions by the computer or the experts recorded, including the majority opinion ...
... • All data recorded and given, if asked for, by the computer or a human expert • All decisions by the computer or the experts recorded, including the majority opinion ...
DEALING WITH OUTBREAKS OF SUSPECTED VIRAL
... Exclude any staff who are ill for 48 hours after symptoms have resolved Minimise staff and patient movements between “wards”/floors/areas Advise visitors that they may be exposed to infection, advise not to visit if feeling unwell Do not discharge patients who may be incubating infection to other in ...
... Exclude any staff who are ill for 48 hours after symptoms have resolved Minimise staff and patient movements between “wards”/floors/areas Advise visitors that they may be exposed to infection, advise not to visit if feeling unwell Do not discharge patients who may be incubating infection to other in ...
Acute heart failure syndrome (AHFS)
... Initially 0.1 mcg/kg/min and titrate to 0.2 to 0.3 mcg/kg/min, up to 0.75 mcg/kg/min Effects on HF symptom and sign - uncertain Not indicated for routine use as an adjunct to standard therapy in patients with an exacerbation of HF. Increase mortality in patients with CAD extreme caution in patients ...
... Initially 0.1 mcg/kg/min and titrate to 0.2 to 0.3 mcg/kg/min, up to 0.75 mcg/kg/min Effects on HF symptom and sign - uncertain Not indicated for routine use as an adjunct to standard therapy in patients with an exacerbation of HF. Increase mortality in patients with CAD extreme caution in patients ...
Physician`s Prescribing Information Etopan XL 400 and 600 mg
... Etopan XL, the dose and frequency should be adjusted to suit individual patient’s needs (tolerance and response). In responsive patients, partial symptomatic relief of symptoms usually occurs within 1 or 2 weeks, although maximum effectiveness may occur only after several weeks of therapy. During lo ...
... Etopan XL, the dose and frequency should be adjusted to suit individual patient’s needs (tolerance and response). In responsive patients, partial symptomatic relief of symptoms usually occurs within 1 or 2 weeks, although maximum effectiveness may occur only after several weeks of therapy. During lo ...
4.2 Posology and method of administration
... Since inhibition of the hematopoietic system is the main risk associated with NAVELBINE®, close haematological monitoring should be undertaken during treatment (determination of hemoglobin level and the leukocyte, neutrophil and platelet counts on the day of each new administration). The dose limiti ...
... Since inhibition of the hematopoietic system is the main risk associated with NAVELBINE®, close haematological monitoring should be undertaken during treatment (determination of hemoglobin level and the leukocyte, neutrophil and platelet counts on the day of each new administration). The dose limiti ...
Systemic lupus erythematosus
... T cells that are reactive with several nuclear autoantigens have been isolated from the peripheral blood of SLE patients. T cells from SLE patients also display abnormal signalling and secrete cytokines that promote inflammation. Regulatory T cells (cells important in maintaining cell tolerance) hav ...
... T cells that are reactive with several nuclear autoantigens have been isolated from the peripheral blood of SLE patients. T cells from SLE patients also display abnormal signalling and secrete cytokines that promote inflammation. Regulatory T cells (cells important in maintaining cell tolerance) hav ...
QLT INC/BC - Novelion Therapeutics Inc.
... AMD is the leading cause of legal blindness in people over the age of 50. Its associated vision loss has been shown to significantly decrease quality of life. Everyday tasks such as driving and walking can be severely affected. Awareness of the condition and treatment in the initial stages of the di ...
... AMD is the leading cause of legal blindness in people over the age of 50. Its associated vision loss has been shown to significantly decrease quality of life. Everyday tasks such as driving and walking can be severely affected. Awareness of the condition and treatment in the initial stages of the di ...
Wilson`s disease for patients and families
... How have I or my child got this condition? Wilson's disease is a genetic disorder. This means that it is not brought about by anything that may have occurred during pregnancy, neither is it an infectious or contagious disease. Genetic disorders are inherited and the pattern in which you or your chil ...
... How have I or my child got this condition? Wilson's disease is a genetic disorder. This means that it is not brought about by anything that may have occurred during pregnancy, neither is it an infectious or contagious disease. Genetic disorders are inherited and the pattern in which you or your chil ...
VPRIV- velaglucerase alfa injection, powder, lyophilized, for solution
... 5.1 Hypersensitivity Reactions Hypersensitivity reactions have been reported in patients in clinical studies with VPRIV [see Adverse Reactions (6.1)]. As with any intravenous protein product, hypersensitivity reactions are possible, therefore appropriate medical support should be readily available w ...
... 5.1 Hypersensitivity Reactions Hypersensitivity reactions have been reported in patients in clinical studies with VPRIV [see Adverse Reactions (6.1)]. As with any intravenous protein product, hypersensitivity reactions are possible, therefore appropriate medical support should be readily available w ...
Klinikiniai atvejai Two Clin i cal Cases of VGKC An ti bod ies As so ci
... of this disorder and are probably not pathogenic. A diagnosis of Hashimoto encephalopathy is unlikely for this patient because he lacks several clinical characteristics including tremor, myoclonus, and stroke like episodes [10–12]. Cancer must be screened for in all VGKCautoantibody- positive patien ...
... of this disorder and are probably not pathogenic. A diagnosis of Hashimoto encephalopathy is unlikely for this patient because he lacks several clinical characteristics including tremor, myoclonus, and stroke like episodes [10–12]. Cancer must be screened for in all VGKCautoantibody- positive patien ...
icu sedation guidelines - Surgical Critical Care. Net
... intended to replace clinical judgment or dictate care of individual patients. ...
... intended to replace clinical judgment or dictate care of individual patients. ...
Trimipramine
... adapted to the requirements of each individual patient. Treatment should be initiated at the lowest recommended dose and increased gradually, noting carefully the clinical response and any evidence of intolerance. It should be kept in mind that a lag in therapeutic response usually occurs at the ons ...
... adapted to the requirements of each individual patient. Treatment should be initiated at the lowest recommended dose and increased gradually, noting carefully the clinical response and any evidence of intolerance. It should be kept in mind that a lag in therapeutic response usually occurs at the ons ...
Hot Flashes: Evidence-Based Review of Alternative Therapies
... trigger an exaggerated response due to (1) In other words: It’s all in a patient’s head! ...
... trigger an exaggerated response due to (1) In other words: It’s all in a patient’s head! ...
Kozlowski outline
... HVF/OCT correlation in this patient as evidence of trans-synaptic degeneration of nerve axons secondary to MS o Role of OCT in Managing MS Patients: Present and Future Relationship between OCT and brain atrophy Evidence exists to support the idea that retinal degeneration measured by OCT refle ...
... HVF/OCT correlation in this patient as evidence of trans-synaptic degeneration of nerve axons secondary to MS o Role of OCT in Managing MS Patients: Present and Future Relationship between OCT and brain atrophy Evidence exists to support the idea that retinal degeneration measured by OCT refle ...
New Concepts in Ocular Surface Infection and Inflammation
... – Stopping cold turkey causes these white cells to proliferate and increase the production of inflammatory cytokines – This means more steroids for a longer period of time which increases the risk of side effects ...
... – Stopping cold turkey causes these white cells to proliferate and increase the production of inflammatory cytokines – This means more steroids for a longer period of time which increases the risk of side effects ...
Superior Labral Tears
... patients had excellent pain relief •At 2-year -- this number decreased to 63%. •45% of these patients returned to their preinjury level of athletic activity. Cordasco et al, AJSM 1993 ...
... patients had excellent pain relief •At 2-year -- this number decreased to 63%. •45% of these patients returned to their preinjury level of athletic activity. Cordasco et al, AJSM 1993 ...
Social Anxiety Tied to Overabundance of Serotonin
... Poor sleep is associated with negative mood in women with bipolar disorder, according to researchers at Penn State College of Medicine and University of Michigan Medical School. Bipolar disorder is a brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry ...
... Poor sleep is associated with negative mood in women with bipolar disorder, according to researchers at Penn State College of Medicine and University of Michigan Medical School. Bipolar disorder is a brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry ...
Psychiatric manifestations of autoimmune diseases – diagnostic and
... with the introduction of biological disease-modifying drugs and special therapeutic strategies that timely combine different medications to achieve remission. Such approach means increased treatment efficacy, better quality of life and decreased incidence of psychosocial problems in RA patients. Unf ...
... with the introduction of biological disease-modifying drugs and special therapeutic strategies that timely combine different medications to achieve remission. Such approach means increased treatment efficacy, better quality of life and decreased incidence of psychosocial problems in RA patients. Unf ...
Drugs for Inflammation, Fever, and Allergies Expanded Key Concepts
... The H1 receptor antagonists, commonly known as antihistamines, are used to treat allergies and inflammation. Antihistamines are most effective when taken prophylactically to prevent allergic symptoms. They are also among the few drugs available to treat vertigo, a form of dizziness that causes signi ...
... The H1 receptor antagonists, commonly known as antihistamines, are used to treat allergies and inflammation. Antihistamines are most effective when taken prophylactically to prevent allergic symptoms. They are also among the few drugs available to treat vertigo, a form of dizziness that causes signi ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.